Silverarc Capital Management, LLC Mersana Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

$402 Million
Q3 2024

A detailed history of Silverarc Capital Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,585,786 shares of MRSN stock, worth $3.14 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

1,585,786

Previous 2,500,585 36.58%

Holding current value

$3.14 Million

Previous $5.03 Million 40.37%

% of portfolio

0.75%

Previous 1.43%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.23 - $2.25 $1.13 Million - $2.06 Million	-914,799 Reduced 36.58%	1,585,786 $3 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $4.45 $936,426 - $2.08 Million	-468,213 Reduced 15.77%	2,500,585 $5.03 Million
Q1 2024 May 14, 2024	SELL	$2.16 - $5.94 $7.45 Million - $20.5 Million	-3,451,338 Reduced 53.76%	2,968,798 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $1.58 Million - $3.32 Million	1,420,136 Added 28.4%	6,420,136 $14.9 Million
Q3 2023 Nov 13, 2023	BUY	$1.06 - $3.91 $4.24 Million - $15.6 Million	4,000,000 Added 400.0%	5,000,000 $6.35 Million
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $1.42 Million - $4.39 Million	459,941 Added 85.16%	1,000,000 $3.29 Million
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $2.4 Million - $4.21 Million	-600,123 Reduced 52.63%	540,059 $2.22 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $825,515 - $1.15 Million	146,109 Added 14.7%	1,140,182 $6.68 Million
Q3 2022 Oct 28, 2022	BUY	$4.63 - $8.0 $667,057 - $1.15 Million	144,073 Added 16.95%	994,073 $6.72 Million
Q2 2022 Jul 25, 2022	BUY	$2.84 - $5.0 $2.41 Million - $4.25 Million	850,000 New	850,000 $3.93 Million
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $1.07 Million - $1.81 Million	-125,123 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $1.33 Million - $1.81 Million	100,123 Added 400.49%	125,123 $1.7 Million
Q1 2021 May 18, 2021	BUY	$15.31 - $26.52 $217,968 - $377,565	14,237 Added 132.28%	25,000 $405,000
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $181,248 - $296,951	10,763 New	10,763 $286,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $192M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Mersana Therapeutics, Inc. Transaction History